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Alanine-scanning mutagenesisWW domains harbor substrates containing proline-rich motifs, but the substrate speciﬁcity and
binding mechanism remain elusive for those WW domains less amenable for structural studies,
such as human WWP2 (hWWP2). Herein we have employed multiple techniques to investigate
the second WW domain (WW2) in hWWP2. Our results show that hWWP2 is a specialized E3 for
PPxY motif-containing substrates only and does not recognize other amino acids and
phospho-residues. The strongest binding afﬁnity of WW2, and the incompatibility between each
WW domain, imply a novel relationship, and our SPR experiment reveals a dynamic binding mode
in Class-I WW domains for the ﬁrst time. The results from alanine-scanning mutagenesis and mod-
eling further point to functionally conserved residues in WW2.
 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
WWP2 (WW domain-containing protein 2), is an E3 ubiquitin
ligase belonging to the NEDD4-like protein family [1]. The nine
members of the family share a similar domain architecture
(Fig. 1), including a C2 (protein kinase C conserved region 2)
domain at the N-terminus, and a HECT (homologous to E6-AP C
terminus) domain at the C-terminus. In order to protect substrate
proteins, as well as, E3 ligases themselves from excessive ubiquiti-
nation and degradation, WW domains in the central structure pro-
vide ﬂexibility so that the C2 domain binds in the vicinity of the
catalytic cysteine to interfere with the formation of the Ubthioester. This inactive form is kept until a docked adaptor or sub-
strates unlock the molecule [2], leading to activation.
A binding mode has been proposed for NEDD4 family E3s – for
instance, another E3 in this family, Smurf2 could accommodate
adaptor molecules, such as Smad7, via WW domains [3]. In this
model, Smad7 binds the WW domains of inactive Smurf2 and
releases the catalytic center in the HECT domain masked by the
C2 domain. Next, Smurf2 is activated to recruit E2 with the aid of
an adaptor for substrate selection. This mechanism is supported
by structural studies made possible by ‘‘well-behaved’’ protein
samples suitable for structure determination [4,5]. However, no
adaptor has been reported to mediate the aforementioned
adaptor-facilitated mode in vivo. Moreover, cell biology studies
indicate the existence of a direct-binding mode for WWP2 and
its substrates [6,7]. Isolated intact WWP2 protein is inactive alone
in vitro, but the addition of substrate could activate WWP2 in a
ubiquitination assay [2,8]. This implies that certain intermediate
elements, like Smad7 [9], are not required for E3 ligases containing
the same kind of WWP1 and WWP2 [7,8,10]. Surprisingly,
although WWP2 also recognizes the same PPxY motif in Smad7,
Smad7 was revealed to be a substrate of WWP2 for ubiquitination,
rather than an adaptor as for Smurf2. The two modes are playing
an important role in regulating the activation of the nine E3s in
NEDD4 family triggered by an unclear mechanism, which raises
the question: what determines the two scenarios of Smad7
Fig. 1. Analysis of the relationship between E3 ligases in the Nedd4 family.
Phylogenetic tree of the nine E3 ligases in the Nedd4 family constructed using the
method of Neighbor-Joining sequence alignment. Rather than comparing entire
domains, full length sequences of human E3s were analyzed. Numbers represent
the proportional lengths of the phylogenetic distance between sequences.
Fig. 2. Alignment of the second WW domain of human WWP2 (hWWP2-WW2),
WW2 and the 4 WW domains of human ITCH (hITCH-WW). Corresponding
database accession numbers are AAC51325 and BAB39389, respectively. The
consensus line shown is based on the alignment of hWWP2-WW2 and hITCH-
WW3. In order to discuss the critical amino acids of WW domains, we deﬁned a
numbering system for amino acids of WW domains based on the residue number of
hWWP2 and hITCH. The number 413 in blue marks the 413rd valine in the hITCH
sequence. The remaining numbers on the top of this panel correspond to the
individual residues of hWWP2-WW2, respectively. Conﬁrmed critical amino acids
of Class-1 WW domains are represented in black, while potentially critical residues
which vary in different Class-I WW domains which require further investigation for
each respective domain are represented in red. The identity of each sequence is
labeled on the left. Sequence identity of each of the four hITCH WW domains
relative to hWWP2-WW2 is indicated on the right. As the standard, hWWP2-WW2
is 100% identical.
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grouped into two groups, adaptor-facilitated and direct-binding.
E3s in the latter group perform ubiquitination in a
‘‘Bind-and-Done’’ manner, while the exact extent of ubiquitination
in the former group is controlled by the adaptor. In addition to
other regulatory mechanisms, such as post-translational modiﬁca-
tion and gene manipulation, the two binding modes reﬂect a deli-
cate balance in ubiquitination regulation and substrate selection
by the WW domain.
The WW domain was identiﬁed in the Yes-associated protein
(YAP) [11], its name derived from the two highly conserved trypto-
phan (W) residues separated by 20-23 amino acid residues. As the
smallest module in nature, the WW domain is stable as a twisted
three-stranded anti-parallel b-sheet without ligands, disulﬁde
bonds or ions [12,13]. The WW domain rarely exists alone; instead,
they tend to be embedded in proteins to promote folding [14] and
maintain stability, such as in dystrophin and YAP65. WW domains
attracted more attention when the importance of WW
domain-containing proteins in a wide array of biological processes,
including transcription, differentiation and ubiquitination, was
noticed [15–18]. Furthermore, there has been growing evidence
of theWWdomain being implicated in many human diseases, such
as hypertension, Huntington’s diseases and cancer [19–21]. In
these diseases, the functional importance of the WW domain is
represented by complexes formed by the WW domain and its
ligand. Mutations of critical residues in the WW domain could
abrogate the binding to substrates and lead to disease. Most
recently, it has been validated that two syndromes,
Golabi-Ito-Hall syndrome of intellectual disability and Liddle syn-
drome of hypertension are caused by loss-of-function point muta-
tions [22,23].
ITCH is another E3 ligase in the Nedd4 family; the structures of
single and tandem WW domains of ITCH – i.e. WW3, WW4 and
WW34 – in complex with a PPxY peptide have been determined.
WW domains from hWWP2 and hITCH show a high conservation
in sequence (Fig. 2). WW2 of hWWP2 shares similarity with the
individual WW domains of hITCH, ranging from 55% to 80%. For
WW3 of hITCH, the sequence identity is 67%, which is only second
to WW2 of hITCH. In the Nedd4 family, WWP1, WWP2 and ITCH
are the most closely related in the phylogenetic tree, however
the substrates are different. Although C2 domains and HECT can
be involved in protein interaction in some cases [3,8,24,25],
NEDD4 family proteins recruit substrates mainly by the WW
domains. As such, WW domains which are classiﬁed as
‘‘direct-binding’’ deserve more attention and in-depth work is
required to illuminate the mechanism by which preferred sub-
strates are selected through only minor difference in the structures
of the respective WW domains.WW domains recognize proline-rich motifs in substrates [26–
28]. Based on differences in these substrate motifs [29–32], WW
domains have been grouped into ﬁve categories with Class-I WW
domains being the most abundant [33]. Different residues deter-
mine the diversity in substrate ligands and WW domains become
versatile platforms connecting parallel networks together [34–
37]. In order to investigate the recognition mechanism, structural
studies have been attempted for both single WW domains and
substrate-bound complex [23,38], including Nedd4 WW domain
with peptide [39]. Unfortunately, some WW domains are not
amenable for structure studies and very difﬁcult to work with
due to their undesirable properties such as insolubility, tendency
of aggregation and conformational ﬂexibility [40]. For WWP2, no
structures have been determined (Supplementary Table S1); only
domain structures of the closely associated family members have
been characterized by NMR [2,41] or X-ray crystallography
[9,42]. Furthermore, the lack of suitable protein samples also hin-
ders function study. For example, it is known that WWP2 binds
PPxY motif-containing substrates [10,43]. As such, all of the cur-
rent research work on WWP2 has been focusing on determining
its substrate [44–47]. In contrast, little progress has been made
on the structure based analysis and characterization of binding
substrates. It is still ambiguous as to whether the WW domain of
WWP2 could recognize other motifs and phosphorylated residues
[28,48]. Furthermore, the structure basis underlying binding of
WWP2 to PPxY motifs remains unclear. Collectively, these deﬁ-
ciencies signiﬁcantly hamper the functional understanding of
WW domains in WWP2 and other WW domain-containing
proteins.
In the past, researchers performed peptide screening [29,49,50]
to map critical residues in several WW domains [32] and even
attempted prediction methodologies [51]; however, many critical
questions are yet to be answered. Herein, we have employed alter-
native and multiple approaches to characterize WW domains not
suitable for conventional structure study (such as WW2 of
hWWP2) in order to provide insights into E3 ligases and their sub-
strate binding.
2. Methods
2.1. Plasmid construction
WW domain proteins were expressed with either a GST or
MBP-tag at the N-terminus (Table 1). Four single WW domains
Table 1
Constructs of WW domains of hWWP2.
Namea Single WW domain Tandem WW domains
WW1 WW2 WW3 WW4 WW12 WHP2c WW1234
Vector pGEX6P1 pET28a pET28a pGEX6P1 pGEX6P1 pET-Duet1 pGEX6P1
Fusion Tag No expb MBP MBP GST GST His GST
a The numbers after ‘‘WW’’ stands for the existence of the numbered WW domain in this construct, for example, WW1 means the ﬁrst WW domain only and, accordingly,
WW1234 means all of the four WW domains of hWWP2 have been cloned in the same plasmid.
b WW1 constructs failed in the expression of desired protein.
c WHP2 was used as a replacement of WW34 truncation.
Table 2
Synthesized peptide used for binding experiments.
SP Amino acid
sequencea
WW
classb
Originalc Afﬁnityd
T1 RRPCPPPYEFC 1 OCT4-N [43] Yes
T2 RTPPPLPP 2 FBP-11 [58] n.be
T3 PPGPPPRGPPP 3 FBP21 [59] n.b
T4 PPPRGPPP 3 FE56 [32] n.b
T5 RLIPPPPPLPPR 5 PRP40 [60] n.b
T6 TRHPPVLTPPDQE 4 PKC-beta, isoform II
[32]
n.b
T7 RDFAFSPPPG 4 OCT4-N [48] n.b
T8 RTLGSPMHSN 4 OCT4-C [28] n.b
a Critical amino acids for binding corresponding WW domain are marked
underline. Phosphorylated amino acid is marked in italic.
b This indicates various Classes of WW domain.
c The original source of this peptide in nature.
d Afﬁnity of this peptide to WT-WW2.
e n.b means no binding was observed.
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structs containing WW12, WW34 and WW1234 were named
accordingly. For alanine-scanning mutagenesis, 23 residues within
the two Trp residues of WW2 were mutated to Ala, respectively.
WHP2 plasmid was prepared as described [52] (Supplementary
materials).
2.2. Protein and peptide
Proteins were expressed in BL21 (DE3) bacterial cells and puri-
ﬁed using an HisTrap HP column followed by a Superdex200 16/60
column (GE Healthcare) with Tris–HCl buffer (25 mM Tris–HCl, pH
8.0, 150 mMNaCl). As shown in Table 2, peptides were synthesized
chemically (Supplementary materials).
2.3. ITC and SPR
Experiments were performed on a VP-ITC microcalorimeter
(MicroCal, Inc.) at 25 C. The protein samples and peptides were
dissolved in Tris–HCl buffer (25 mM Tris–HCl, pH 8.0, 150 mM
NaCl). A solution of 1 mM peptide was titrated into 50 lM fusion
proteins. Surface plasma resonance (SPR) was performed on a
BiaCore T200 (GE Healthcare) using a sensor chip CM5 at 20 C.
The ligand was MBP-WW2 and the peptides were dissolved in
HEPES buffer (10 mM HEPES, pH 7.4, 3 mM EDTA, 150 mM NaCl,
0.005% Tween20) as analytes. Data was analyzed using software
BiaCore T200 Evaluation (Supplementary materials).
2.4. Structure modeling
A crystal structure of the WW3 domain of ITCH (PDB code:
4ROH) was employed as the template. Three structures were mod-
eled, including WT-WW2 (wide-type) and two mutants (F346A,
Y347A). The Amber99SB force ﬁeld was used for all the calcula-
tions. The electrostatic interactions were calculated by using theParticle-mesh Ewald algorithm. Full molecular dynamic (MD) cal-
culation was carried out. The binding free energies were calculated
using the MM-PBSA method (Supplementary materials).
3. Results
3.1. Plasmid construction and protein expression
We expressed WW2 and WW3 with an MBP-tag, and WW2,
WW4, WW12, WW1234 with a GST-tag. For WW34, we also pre-
pared WHP2 as a replacement which contains WW34 and HECT
domain. Various buffers had been tested for tag cleavage, but all
the cleaved domains experienced aggregation. Hence the existence
of either an MBP or GST-tag was required for soluble, homoge-
neous preparation of the WW domain and its variants.
3.2. Peptide binding
Isothermal titration calorimetry (ITC) experiments revealed
that, out of eight peptides, various single WW domains bind only
to the T1 peptide (RRPCPPPYEFC) (Table 3). As a control, neither
GST nor MBP exhibited binding to any of the peptides. The T1 pep-
tide contains a PPxY motif derived from the OCT4 protein which
had been proven to bind WWP2 via this sequence [43].
Interestingly, no binding to the T1 peptide was detected for tan-
dem WW domains. Although absent in our experiments, WW1 of
WWP2 was reported to bind PPxY substrates [53]. Our results sug-
gest that WW domains of WWP2 are reminiscent of the Class-I
WW domain.
In our SPR experiment, WW2 showed a typical dynamic binding
mode (Fig. 3). The transition between association and dissociation
was so rapid that it was not possible to collect sufﬁcient data
points for association and dissociation analysis. Again, the remain-
ing peptides did not show any binding by SPR. It further supports
that WWP2 is a specialized E3 for PPxY motif-containing substrate
via its Class-I WW domains.
3.3. Alanine scanning and structure modeling
In our alanine-scanning experiment, most mutants generated
soluble proteins. On the basis of peptides binding experiments,
T1 peptide (RRPCPPPYEFC) was used to titrate puriﬁed mutant pro-
teins to investigate the importance of potentially critical residues
for substrates binding. Mutation to Ala signiﬁcantly compromised
the binding of most mutants, with the exception of F346A which
retained most of the original binding afﬁnity (Fig. 4B).
Based on alanine scanning result and the template structure, we
modeled three structures, WT-WW2, F346A-WW2 and
Y347A-WW2 (Fig. 5A–C). From MD trajectories, we found two dif-
ferent structures alternatively appearing before 65 ns (Fig. 5F); one
aligns well with the template structure of ITCH WW3 in tandem
WW34 (PDB: 4ROH), while the other aligns well with the crystal
structure of single ITCH WW3 (PDB: 4RRE). Despite the minor dif-
ference in the ﬁrst b-sheet resulting from T340 (Fig. 5G), the overall
Table 3
The afﬁnities of T1 peptide for WW domains of WWP2.
Protein WW2 WW3 WW4 WW12 WHP2 WW1234 WW2-Y346A
Apparent Kd (lM)a 53±8 42±11 29±17 n.bb n.b n.b 260 ± 25
a Equilibrium binding constants were determined as described in Section 2. Kd values are quoted with the standard errors from curve ﬁtting.
b n.b means no binding was observed.
Fig. 3. Representative SPR sensorgrams and result analysis. A series of binding
experiments for the synthesized peptides to hWWP2 WW2 domain is shown. The
hWWP2WW2 domain was fused with MBP tag and immobilized onto a CM5 sensor
chip as the ligand. Peptides were used as analytes in the binding experiment. A ﬂow
cell without ligand was set as the control which was subtracted from the
sensorgrams shown here. Because other peptides did not bind the ligand, only
the sensorgrams of T1 peptide was represented here. The analyte was diluted for
analysis at different concentrations. The sensorgrams shown above was plotted
against the RUeq values. As marked in the chart, C stands for a control result
without analyte in buffer. Each number next to a colored line stands for the order of
sample analyzed. In the 12th run, the analyte was identical to that in run 8. That
was a positive control to mark the drift of the baseline and in this work, it roughly in
the expected position. All data have been repeated to ensure the validity and the
curves in the sensorgram were averaged manually and the analyte concentration in
each run was summarized (Supplement Table S3).
1938 J. Jiang et al. / FEBS Letters 589 (2015) 1935–1942conformation of the two WT-WW2 structures are very similar to
the template and the critical Y347 is virtually unchanged (Fig. 5H).
In contrast, the orientation of F346 was found to be away from
the binding site with no contribution to the binding itself.Fig. 4. Comparison of values against the T1 peptide titration measured by ITC. (A) WW do
transferred by DS from measurement and DG was calculated as equation: DG = DH
Identiﬁcation of critical amino acids in the formation of a WW2-PPXY complex by alani
such as Y347, T356 andW358, which correlates with properties common to Class-I WW d
attain the results. Because the binding afﬁnities of most of the variant to T1 peptide
estimating the scale of heat released from titration. In some variants, heat from non-spe
was used to prepare the ﬁgure. WT-WW2was set as the control and retained 100% bindin
of individual residue was presented. The three residues marked by ⁄ correspond to mutMoreover, replacement of F346 by Ala did not destabilize the over-
all structure (Fig. 5D). Unlike its corresponding role in hITCH
(Supplementary Fig. S1), F346 in hWWP2 did not interact directly
with critical amino acids and the impact on these critical amino
acids was compromised. Consequently, the F346A mutation
resulted in changes inside the WW2 structure (Fig. 6C) but without
inﬂuencing the binding pocket signiﬁcantly (Fig. 6A). As such, the
F346A mutant retained the most binding afﬁnity which allowed
it to serve as a control for subsequent computational analyses.
While the structure of the Y347A-WW2 derivative remained
stable relative to the wild-type (Fig. 5E), mutation to the Tyr resi-
due to Ala removed interaction with P2 in the PPxY peptide
(Fig. 6D). Consequently, this lack of constraint allowed P2 to move
away (Fig. 6B). When amino acids playing important roles in both
binding substrate and connecting structurally crucial residues was
inﬂuenced, the mutation of Y347 led to the shift of the structural
amino acids and further crippled the binding afﬁnity of Y347A
towards the PPxY peptide.
An analyses of free energies demonstrated that, while the bind-
ing free energy of the F346A-WW2 mutant is similar to that of
WT-WW2 (Table 4), the binding energy of the Y347A mutant is rel-
atively small, only 4.21 kcal/mol. These results are consistent
with the results of peptide binding experiments using F346A and
Y347A. In computational analyses, Y347A, T356A and W358A
mutants all exhibited the same dramatic decrease in binding free
energy (Supplementary Table S2).
4. Discussion
Among the WW domains extensively characterized [54], WW2
and WW3 of Smurf2 cooperate closely to bind the same peptide
[38]. In contrast, tandem WW domains of hWWP2 demonstrated
no binding. In protein preparation, no signiﬁcant difference was
found in the eluate volume of gel ﬁltration between tagged WW
proteins. This indicates that tandem WW domains could form amains of hWWP2 bind substrate peptide in a priority-dependent manner. TDSwas
 TDS. Data used here was from averaged results of repeated experiments. (B)
ne scanning. Analyses revealed several amino acid residues are important in WW2,
omains. As described above, the same experimental conditions have been utilized to
were compromised and could not be ﬁtted reasonably, the data was collected by
ciﬁc binding was subtracted from the result as background and the averaged result
g afﬁnity which was indicated by the number on the left. At the bottom, the number
ants for which WW fusion proteins could not be generated.
Fig. 5. Modeled structures of WT-WW2 and two mutants (F346A, Y347A). RMSD of the frames sampled in MD simulations to the initial reference structures: (A) WT-WW2.
(B) Y347A. (C) F346A. Alignment structures of WT-WW2 and two mutants: (D) WT-WW2 (green) and F346A (cyan). (E) WT-WW2 (green) and Y347A (magenta). Alignment
structures of two modeled WT-WW2 using MD trajectories and two crystal structure of hITCH WW3: (F) overall structures in ribbon, hITCH WW3 (green and cyans), WT-
WW2 (yellow and magenta). (G) Difference of the four structures lead by T340 in WT-WW2 and T407 in hITCH WW3. (H) Y347 in WT-WW2 and Y414 in hITCH WW3 in the
four structures kept unchanged.
Fig. 6. Comparison of interesting amino acids in WT-WW2 and mutants (F346A, Y347A) thereof. Structures were aligned and less important amino acids were not presented.
(A) Structural differences resulted by mutation F346A. Green stick: WT-WW2. Cyan line: F346A-WW2. Individual amino acid residues are numbered in accordance with the
exact corresponding position in hWWP2. F346 marks 346th Phe in WT-WW2 presented as green stick while the nearby F364A in Cyan represents mutation of original Phe to
Ala. Accordingly, the other two amino acids, K338 and T340 were marked to represent the differences. (B) The detailed representation of Y347 in WT-WW2, F346A and
alanine in Y347A. Green: WT-WW2. Cyan: F346A. Magenta: Y347A. The mutation of F346 to alanine brought on little change in Y347. PPPY was marked as the source of the P
in white which was exhibited on the top. The structural changes of interested amino acids in F346A (C) and Y347A (D). Green line: WT-WW2. Cyan stick: F346A-WW2.
Magenta stick: Y347A. Individual amino acids were numbered as described above.
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Table 4
The MM-PBSA score for the wide-type WW2 and mutants (kcal/mol).
Energy components WT F346A Y347A
DHPB 42.02 44.48 40.26
DHGB 37.62 40.48 38.71
TDS 31.35 35.14 36.05
DGPB 10.67 9.34 4.21
DGGB 6.27 5.34 2.66
1940 J. Jiang et al. / FEBS Letters 589 (2015) 1935–1942tighten structure, so the exact increase in molecular weight could
not result in corresponding change in elute proﬁle. Thus, the loss
in binding ability may be attributed to the strong inter-molecular
interactions which could not be alleviated or interrupted by sub-
strate peptide. Consequently, the incompatibility between WW
domains of hWWP2 determines the difﬁculty in structure determi-
nation and raises the probability that WW domains of hWWP2
may work alone in binding substrates.
The apparent Kd determined for individual WW domain of
hWWP2 in our ITC results is similar to that of WW3 of mNedd4
which is also speciﬁc for PPxY substrates [55]. It implies that the
same afﬁnity and substrate speciﬁcity are determined by the high
sequence similarity and especially, conserved residues in WWs of
WWP2 and WW3 of Nedd4. It has been reported that the WW2
domain of WWP2 is capable of binding more substrate than the
other WW domains in WWP2 [10,43,44,53]; however, the
determined Kd value did not support this claim as expected.
Furthermore, differences have been found in other parameters,
such as DH and DG (Fig. 4A). The DH reﬂects the heat released in
titration and, in the case of WW2, DH was high (Fig. 4A). Our
results coincide with previous reports that claim that WW2 has
the strongest binding afﬁnity in vitro [53]. Due to redundancy in
behavior, WW1 interacted with WW2 to abolish the binding of
WW12 in our work. However, a recently publication has
caused resulted in an additional question as it was found that
native WW1 fused with the C2 domain failed to bind substrates
in mammalian cells [6]. This implies that the actual importance
of WW1 in binding substrates may be much less than anticipated.
As such, more work is needed to reveal whether an unknown
antagonistic mechanism regulates the WWs in WWP2. Taken
together, we conclude that WWP2 binds PPxY substrates via its
WW domains in a priority dependent manner with WW2 playing
the lead role.
According to our SPR results, WW2 is the ﬁrst of the Class-I WW
domains found to display a dynamic binding mode. Such a binding
mode was ﬁrst found in Class II/III WW domains [56]. Compared
with the fast on/off binding mode of Class-IV WW domains [55],
a dynamic binding mode indicates an increased stability of the pro-
tein complex; however, the binding pattern of WW2 seems com-
promised. As a result, the actual stability of complexes formed
betweenWW2 and its substrates is signiﬁcantly weaker than those
involving Class II/III WW domains. Before this current work, there
were two typical binding modes identiﬁed for WW domains.
Herein we have found a typical dynamic binding mode in WW2,
in which the complex stability seems to be at an intermediate level
between the two known modes. These ﬁndings strongly suggest
the existence of a previously unknown, direct-binding mode in
the Nedd4 E3 family (Supplementary Fig. S2). This opens the door
to the possibility of more cases of this kind being discovered in the
future.
In the alanine-scanning experiments, residues between W336
and W358 were sequentially and individually mutated. The Ala
substitution signiﬁcantly impacted the binding of most mutants.
Mutation of W336 and Y348 in the WW2 domain of hWWP2
almost abrogated binding as indicated by ITC titration. It implied
the importance of these two residues to structure stability, as theywere either far away or oriented in a manner away from the bind-
ing pocket for PPxY substrates. Among the mutants, F346A was
quite unique due to its largely retained binding afﬁnity.
According to the determined and modeled structures of the WW
domains, it is well-understood that the two neighboring residues
(F346 and Y348 in WW2) are located on opposing sides of the core
amino acid (Y347 in WW2) and are primarily structural in func-
tion. As a compact domain, the residues around the binding pocket
are of either structural or functional importance, so mutation of
these residues could lead to severe outcomes, as seen with the
Y348A in WW2.
Compared with modeled WT-WW2, both mutants (F346A and
Y347A) demonstrate obvious structural changes. The changes
observed in the F346A mutant are less signiﬁcant than those seen
in the Y347A derivative, which result in virtually no change in the
binding pocket of the former. This ﬁnding substantiates our
alanine-scanning results. In the WW domain of YAP, W177F and
F189Y did not cause obvious change in binding assay [29]. It was
concluded that mutation of amino acids by residues similar in size
may attenuate any structural impact and sustain binding afﬁnity.
Our work proves that mutation to residues of dissimilar size could
have the same effect in the WW domain. It suggests that the WW
domain, upon mutation, adapts a new stable state which incorpo-
rates the change. Thus, the mutant should be treated as a new
molecule with potential changes in both binding afﬁnity and sub-
strate preferences [57].
In our modeled structures, both W336 and E337 are located far
from the binding pocket. Mutations in each of these residues virtu-
ally diminished binding, while neither F346A nor Y347A had any
signiﬁcant impact on E337 (Fig. 6C and 6D). Therefore, we there-
fore suggest that W336 and E337 are structurally conserved. In
contrast, the functionally conserved amino acid residues, such as
T356, W358 and especially Y347 play an important role in the sub-
strate binding of WT-WW2, in a similar manner as T423 and W425
in ITCH WW3. It suggests that changes in binding properties are
determined by the ﬁnal properties of a mutated WW domain,
including binding afﬁnity and substrate type. In our case, original
binding was retained only by the F346A mutant derivative.
Furthermore, the H192G mutation switched the WW1 domain of
YAP from Group I to Group II classiﬁcation [57]. Unlike other stud-
ies, Ala was selected to substitute critical residues to perturb the
WW2 structure; the existence of F346A implied a survived binding
pocket upon mutation. To an extent, identiﬁcation of the F346A
mutant seems serendipitous after an extensive screening and the
equilibrium procedure in structure happened to attenuate the
impact or recover the structure of the binding pocket.
It should be emphasized that we could not rule out other prob-
abilities where the same results could be achieved using different
point mutations or a combination of multiple mutations.
Nevertheless, F346A has effectively served as a control that evalu-
ates our modeled structure of WW domain.
5. Conclusion
We have revealed that WWP2 is specialized to bind PPxY
motif-containing substrates via its Class-I WW domains. The
WW2 domain of hWWP2 exhibits a dynamic binding mode with
the PPxY peptide, a novel mechanism for Class-I WW domains.
Within hWWP2, WW2 plays the leading role in substrate binding
as it exhibits the strongest afﬁnity. Unlike Smurf2, WWP2 takes
on a direct-binding mode without the aid of other binding ele-
ments. Based on alanine-scanning mutagenesis and computation
modeling, we conclude that the key amino acids of the canonical
Class-I WW domains are functionally conserved in hWWP2. Our
modeled structures are substantiated by existing structures and
experiment results. More importantly, our work represents an
J. Jiang et al. / FEBS Letters 589 (2015) 1935–1942 1941alternative approach to the characterization of those WW
domains not amendable to structural studies by NMR and/or
crystallography.
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